Erik Smith, MD, cannabinoid medicine physician, Philadelphia.
G. Malik Burnett, MD, addiction medicine specialist, Baltimore.
U.S. Drug Enforcement Administration. “Drug Scheduling.” (Accessed November 2022).
National Conference of State Legislatures. (2022). “State Medical Cannabis Laws.”
National Academies of Sciences, Engineering, and Medicine. (2017). “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.”
CNN. (2013). “Marijuana Stops Child’s Severe Seizures.”
Psychiatric Clinics of North America. (2022). “Policy Ahead of the Science: Medical Cannabis Laws Versus Scientific Evidence.”
Dialogues in Clinical Neuroscience. (2020). “History of cannabis and the endocannabinoid system.”
Cerebrum. (2013). “Getting high on the endocannabinoid system.”
U.S. Department of Justice and Library of Congress. (2018) “Is Cannabis a Gateway Drug? Key Findings and Literature Review.”
Office of National Drug Policy and the Rand Corporation. (2013). “Improving the Measurement of Drug-Related Crime.”
The Lancet. (2019). “The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.”
Reason Foundation. (2018). “Does Recreational Marijuana Legalization Contribute to Homelessness?”
Colorado Department of Public Health & Environment. (2020). “THC Concentration in Colorado Marijuana: Health Effects and Public Health Concerns.”
Cato Institute. (2021). “The Effect of State Marijuana Legalizations: 2021 Update.”